Trends in Prescribing of Selected Alpha-Blockers in General Practice in England

0

500,000

1,000,000

1,500,000

2,000,000

2,500,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Doxazosin Tamsulosin Alfuzosin Indoramin Terazosin Prazosin

© Copyright NHSBSA 2008

Trends in Spending on Selected Alpha-Blockers in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

35,000,000

40,000,000

45,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Doxazosin Tamsulosin Alfuzosin Indoramin Terazosin Prazosin

© Copyright NHSBSA 2008

Trends in Prescribing of Anti-Obesity Drugs in General Practice in England

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Orlistat Sibutramine Rimonabant

© Copyright NHSBSA 2008

Trends in Spending on Anti-Obesity Drugs in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

14,000,000

16,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Orlistat Sibutramine Rimonabant

© Copyright NHSBSA 2008

Trends in Prescribing of Blood Glucose Test Strips, Insulins and Oral Antidiabetics in General Practice in England

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

8,000,000

9,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Blood Glucose Test Strips Insulins Oral Antidiabetic drugs

© Copyright NHSBSA 2008

Trends in Spending on Blood Glucose Test Strips, Insulins and Oral Antidiabetics in General Practice in England

0

20,000,000

40,000,000

60,000,000

80,000,000

100,000,000

120,000,000

140,000,000

160,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Blood Glucose Test Strips Insulins Oral Antidiabetic drugs

© Copyright NHSBSA 2008

Trends in Prescribing of Insulins in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

1,600,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Short-acting Intermediate-acting Long-acting

© Copyright NHSBSA 2008

Trends in Spending on Insulins in General Practice in England

0

10,000,000

20,000,000

30,000,000

40,000,000

50,000,000

60,000,000

70,000,000

80,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Short-acting Intermediate-acting Long-acting

© Copyright NHSBSA 2008

Trends in Prescribing of Short-acting Insulins in General Practice in England

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

450,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Soluble Insulin (Neutral Insulin) Insulin Lispro Insulin Aspart Others

© Copyright NHSBSA 2008

Trends in Spending on Short-acting Insulins in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Soluble Insulin (Neutral Insulin) Insulin Lispro Insulin Aspart Others

© Copyright NHSBSA 2008

Trends in Prescribing of Intermediate and Long-acting Insulin in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Biphasic Isophane Insulin Insulin Glargine Biphasic Insulin Aspart Isophane Insulin Insulin Detemir Biphasic Insulin LisproOthers

© Copyright NHSBSA 2008

Trends in Spending on Intermediate and Long-acting Insulin in General Practice in England

0

10,000,000

20,000,000

30,000,000

40,000,000

50,000,000

60,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Biphasic Isophane Insulin Insulin Glargine Biphasic Insulin Aspart Isophane Insulin Insulin Detemir Biphasic Insulin LisproOthers

© Copyright NHSBSA 2008

Trends in Prescribing of Devices to Deliver Insulin in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Needles for p/f & reusable pen injectors LancetsSyringe with needle AccessoriesReusable pen Others

© Copyright NHSBSA 2008

Trends in Spending on Devices to Deliver Insulin in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Needles for p/f & reusable pen injectors LancetsSyringe with needle AccessoriesReusable pen Others

© Copyright NHSBSA 2008

Trends in Prescribing of Oral Antidiabetic Drugs in General Practice in England

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Biguanides (Metformin) Sulphonylureas Pioglitazone & Rosiglitazone

Rosiglitazone with Metformin Other Antidiabetics

© Copyright NHSBSA 2008

Trends in Spending on Oral Antidiabetic Drugs in General Practice in England

0

10,000,000

20,000,000

30,000,000

40,000,000

50,000,000

60,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Biguanides (Metformin) Sulphonylureas Pioglitazone & Rosiglitazone

Rosiglitazone with Metformin Other Antidiabetics

© Copyright NHSBSA 2008

Trends in Usage of Oral Antidiabetic Drugs in General Practice in England

0

20,000,000

40,000,000

60,000,000

80,000,000

100,000,000

120,000,000

140,000,000

160,000,000

180,000,000

200,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

ADQ

s

Metformin GliclazideRosiglitazone GlimepirideGlibenclamide Rosiglitazone with Metformin Pioglitazone Others

NB. If no ADQ available DDD used.

© Copyright NHSBSA 2008

Trends in Usage of Oral Antidiabetic Drugs in General Practice in England

0

20,000,000

40,000,000

60,000,000

80,000,000

100,000,000

120,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

ADQ

s

Metformin GlibenclamideGliclazide GlimepirideRosiglitazone Rosiglitazone with Metformin Pioglitazone Others

NB. If no ADQ available DDD used.

© Copyright NHSBSA 2008

Trends in Prescribing of Pioglitazone and Rosiglitazone in General Practice in England

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

450,000

500,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Rosiglitazone Pioglitazone

NB. Excluding Rosiglitazone / Pioglitazone with Metformin

© Copyright NHSBSA 2008

Trends in Spending on Pioglitazone and Rosiglitazone in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Rosiglitazone Pioglitazone

NB. Excluding Rosiglitazone / Pioglitazone with Metformin

© Copyright NHSBSA 2008

Trends in Prescribing of and Spending on Pioglitazone with Metformin in General Practice in England

0

1,000

2,000

3,000

4,000

5,000

6,000

7,000

8,000

9,000

10,000

Nov-06

Dec-06

Jan-07

Feb-07

Mar-07

Apr-07

May-07

Jun-07

Jul-07

Aug-07

Sep-07

Oct-07

Nov-07

Dec-07

Jan-08

Feb-08

Mar-08

Apr-08

May-08

Jun-08

Jul-08

Item

s

£0

£50,000

£100,000

£150,000

£200,000

£250,000

£300,000

£350,000

£400,000

NIC

(£)

Items NIC (£)

© Copyright NHSBSA 2008

Trends in Prescribing of and Spending on Rosiglitazone with Metformin in General Practice in England

0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

160,000

180,000

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

£0

£1,000,000

£2,000,000

£3,000,000

£4,000,000

£5,000,000

£6,000,000

£7,000,000

£8,000,000

£9,000,000

NIC

(£)

Items NIC (£)

© Copyright NHSBSA 2008

Trends in Prescribing of Blood Glucose Test Strips in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

1,600,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Active MediSense Advantage Plus One Touch Compact Ascensia Freestyle Aviva Others

© Copyright NHSBSA 2008

Trends in Spending on Blood Glucose Test Strips in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

35,000,000

40,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Active MediSense Advantage Plus One Touch Compact Ascensia Freestyle Aviva Others

© Copyright NHSBSA 2008

Trends in Prescribing of Female Sex Hormonesin General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

1,600,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Opposed oestrogens Unopposed oestrogens Tibolone Progestogens Raloxifene

© Copyright NHSBSA 2008

Trends in Spending on Female Sex Hormones in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Opposed oestrogens Unopposed oestrogens Tibolone Progestogens Raloxifene

© Copyright NHSBSA 2008

Trends in Prescribing of Different Formulations of Opposed and Unopposed Oestrogens in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Tablet Patch Others

© Copyright NHSBSA 2008

Trends in Spending on Different Formulations of Opposed and Unopposed Oestrogens in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Tablet Patch Others

© Copyright NHSBSA 2008

Trends in Prescribing of Dutasteride and Finasteride in General Practice in England

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

450,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Finasteride Dutasteride

© Copyright NHSBSA 2008

Trends in Spending on Dutasteride and Finasteride in General Practice in England

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

8,000,000

9,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Finasteride Dutasteride

© Copyright NHSBSA 2008

Trends in Prescribing of Drugs Affecting Bone Metabolism in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

1,600,000

1,800,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Alendronic Acid (incl. combination with Vit D) Disodium EtidronateRisedronate Sodium Sodium ClodronateStrontium Ranelate Ibandronic AcidOthers

© Copyright NHSBSA 2008

Trends in Spending on Drugs Affecting Bone Metabolism in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

35,000,000

40,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Alendronic Acid (incl. combination with Vit D) Disodium EtidronateRisedronate Sodium Sodium ClodronateStrontium Ranelate Ibandronic AcidOthers

© Copyright NHSBSA 2008

Trends in Prescribing of Low Strength Combined Oral Contraceptives in General Practice in England

0

20,000

40,000

60,000

80,000

100,000

120,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Mercilon Loestrin 20 Femodette Evra

© Copyright NHSBSA 2008

Trends in Spending on Low Strength Combined Oral Contraceptives in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Mercilon Loestrin 20 Femodette Evra

© Copyright NHSBSA 2008

Trends in Prescribing of Standard Strength Combined Oral Contraceptives in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

1,600,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Microgynon & Ovranette Cilest Yasmin Logynon & Trinordiol Marvelon Minulet & Femodene Others

© Copyright NHSBSA 2008

Trends in Spending on Standard Strength Combined Oral Contraceptives in General Practice in England

0

1,500,000

3,000,000

4,500,000

6,000,000

7,500,000

9,000,000

10,500,000

12,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Microgynon & Ovranette Cilest Yasmin Logynon & Trinordiol Marvelon Minulet & Femodene Others

© Copyright NHSBSA 2008

Trends in Prescribing of Progestogen-only Contraceptives in General Practice in England

0

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Oral Injection IU Implant

© Copyright NHSBSA 2008

Trends in Spending on Progestogen-only Contraceptives in General Practice in England

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

8,000,000

9,000,000

10,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Oral Injection IU Implant

© Copyright NHSBSA 2008

Trends in Prescribing of and Spending on Intra-Uterine Progestogen-only Contraceptives in General Practice in England

0

2,500

5,000

7,500

10,000

12,500

15,000

17,500

20,000

22,500

25,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

£0

£500,000

£1,000,000

£1,500,000

£2,000,000

£2,500,000

NIC

(£)

Items NIC (£)

© Copyright NHSBSA 2008

Trends in Prescribing of Drugs to Treat Erectile Dysfunction in General Practice in England

0

100,000

200,000

300,000

400,000

500,000

600,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Sildenafil Tadalafil Alprostadil Vardenafil Others

© Copyright NHSBSA 2008

Trends in Spending on Drugs to Treat Erectile Dysfunction in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

14,000,000

16,000,000

18,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Sildenafil Tadalafil Alprostadil Vardenafil Others

© Copyright NHSBSA 2008

Trends in Prescribing of Drugs to Treat Breast Cancer in General Practice in England

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Tamoxifen Anastrozole Letrozole Exemestane Others

© Copyright NHSBSA 2008

Trends in Spending on Drugs to Treat Breast Cancer in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

14,000,000

16,000,000

18,000,000

20,000,000

22,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Tamoxifen Anastrozole Letrozole Exemestane Others

© Copyright NHSBSA 2008

Trends in Prescribing of Drugs to Treat Prostate Cancer in General Practice in England

0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

160,000

180,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Goserelin Bicalutamide Leuprorelin Cyproterone Others

© Copyright NHSBSA 2008

Trends in Spending on Drugs to Treat Prostate Cancer in General Practice in England

0

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

35,000,000

40,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Goserelin Bicalutamide Leuprorelin Cyproterone Others

© Copyright NHSBSA 2008

Trends in Prescribing of Selected Calcium Supplements in General Practice in England

0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

160,000

180,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Calcium Carbonate Sandocal Calcium Lactate Calcium-Sandoz Calcium Gluconate

© Copyright NHSBSA 2008

Trends in Spending on Selected Calcium Supplements in General Practice in England

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Calcium Carbonate Sandocal Calcium Lactate Calcium-Sandoz Calcium Gluconate

© Copyright NHSBSA 2008

Trends in Prescribing of Ergocalciferol/Colecalciferol Preparations (including Combinations) in General Practice in England

0

500,000

1,000,000

1,500,000

2,000,000

2,500,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Calcichew D3 Forte Calcichew D3 Adcal D3 Calcium & Vitamin D Others

© Copyright NHSBSA 2008

Trends in Spending on Ergocalciferol/Colecalciferol Preparations (including Combinations) in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Calcichew D3 Forte Calcichew D3 Adcal D3 Calcium & Vitamin D Others

© Copyright NHSBSA 2008

Trends in Prescribing of Vitamin D (BNF 9.6.4) in General Practice in England

0

500,000

1,000,000

1,500,000

2,000,000

2,500,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

Item

s

Ergocalciferol/Colecalciferol including Combinations Alfacalcidol Others

© Copyright NHSBSA 2008

Trends in Spending on Vitamin D (BNF 9.6.4) in General Practice in England

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

14,000,000

Jun-03

Sep-03

Dec-03

Mar-04

Jun-04

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Quarter to

NIC

(£)

Ergocalciferol/Colecalciferol including Combinations Alfacalcidol Others

© Copyright NHSBSA 2008